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Purpose:  The  present  investigation  was  aimed  at evaluating  the  anti-ophidian  properties  of
ethnomedicinal  herb  Leucas  aspera  against  Indian  cobra,  Naja  naja  venom  enzymes.
Methods: Methanolic  extract of  Leucas aspera  was  evaluated,  in  vitro,  for its ability  to  inhibit
the major  enzyme  activities  of  Naja  naja venom  including  protease,  phospholipase  A2,
hyaluronidase  and  hemolytic  factors.  The  type  of  phytochemicals  present  in the extract
was analyzed.  Also,  the  major  phytoconstituents  in the extract  was  determined  by  gas
chromatography–mass  spectrometry  (GC–MS).
Results: Venom  protease  and  hyaluronidase  activities  (two  isoforms)  were  completely
(100%)  neutralized  by  the  L. aspera  methanolic  extract  at ratio  of  1:50  w/w (venom:
plant  extract)  and  venom  hemolytic  activity  was  also completely  neutralized  at  a ratio
of 1:80  w/w  by  the  plant  extract.  However,  the  extract  failed  to  neutralize  phospholipase
A2 activity  even  at the  highest  concentration  used. Phytochemical  analysis  revealed  the
presence  of  alkaloids,  acidic  compounds,  ﬂavonoids,  steroids  and  cardiac  glycosides  in
the extract.  GC–MS  analysis  indicated  that  a  total  of  14  compounds  were  present  in the
extract.  The  major  bioactive  constituents  were  found  to be 6-octadecenoic  acid  (32.47%),  n-
hexadecanoic acid  (25.97%),  and  17-octadecen-14-yn-1-ol  (14.22%)  along  with  the  minor
constituents,  sitosterol  (2.45%)  and  stigmasterol  (2%),  which  was  previously  reported  to
exhibit antivenom  activity.
Conclusion: The  results  obtained  demonstrate  for the  ﬁrst time  that the  methanolic  extract
of  Leucas  aspera  possesses  anti-venom  activity  and  could  be considered  as  a potential  source
for the anti-ophidian  metabolites.
© 2014  The  Authors.  Published  by  Elsevier  Ireland  Ltd. This  is  an  open  access  article  under
Y-NC-Nthe CC  B
. Introduction
Since time immemorial man  has been dependent on
lant  sources for food and medicine. Recently, there has
een  renewed attention and interest in the use of tradi-
ional medicine. The World Health Organization (WHO)
stimated that nearly 80% of the population depends on
erbal  medicines to meet primary health care needs due to
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their low cost and availability [1]. In India there are about 54
million  indigenous people of different ethnic groups using
medicinal plants for the treatment of various types of ail-
ments,  including snakebites [2]. Snakebite is often readily
treated by traditional herbal medicines by rural population,
especially in tropical and subtropical countries including
India.
It  is estimated that 1.2 to 5.5 million snakebites occur
globally, with 94,000 deaths occurring annually [3]. In India
alone,  35,000–50,000 deaths were reported every year
[4,5].  The major victims are agriculturists and their families
living  in rural areas of the country. Snake venom is complex
is is an open access article under the CC BY-NC-ND license
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mixture of enzymes, carbohydrates, proteins and several
other  small molecules. Among all enzymes present in the
venom,  proteases, phospholipases, and hyaluronidases are
reported  to be medically important in developing effec-
tive  antidotes [6]. Proteases are known to degrade extra
cellular matrixes and allow other venom components
to access the local tissue. Phospholipases are multifunc-
tional enzymes that degrade membrane phospholipids and
release  arachidonic acid which is a precursor molecule in
causing  inﬂammation by cyclooxygenase (COX) or lipooxy-
genase  (LOX) pathways. Hyaluronidases are spreading
factors which facilitate diffusion of venom toxins from the
site  of bite into general circulation and thereby increase
the severity of envenomation. The only treatment avail-
able  since 1895 is animal derived polyclonal antisnake
venom (ASV) therapy. Despite of its wide usage, due to high
seasonal  and biochemical variations in the venom compo-
sition,  records indicate that ASV developed against big four
venoms  is imprecise and less effective [7] in the treatment
of  snakebite victims. In addition to its high cost, hypersen-
sitive reactions were also reported from the ASV treated
victims [8]. Also, the quantity of the ASV produced does
not  meet the demand. Therefore interest in exploring the
snake  venom antidotes from plant sources has increased.
Hence the present study was aimed to validate the anti-
ophidian activity of the commonly used traditional herbal
plant  Leucas aspera against Naja naja venom enzymes.
2. Materials and methods
2.1.  Plant collection
The  present investigation was carried out by conducting
surveys and questionnaires with tribal people and Iru-
lars  living in Irularpatti, Vallimalai, Alamalrengapuram in
Vellore  district of Tamil Nadu, India and Bangarupalyam,
Punganur and Chittoor in Andhra Pradesh, India. Tradi-
tional healers, called ‘Vaidyars’ from different indigenous
groups were also approached for the documentation of
the  medicinal plants used in the treatment of snakebite.
The plant species collected was identiﬁed by a Botanist Dr.
Madhavachetty, Department of Botany, Sri Venkateswara
University, Tirupati, Andhra Pradesh and a voucher spec-
imen  (voucher no: 1200) was deposited in the same
department.
2.2. Plant extraction
Five  hundred grams of shade dried powdered plant
material was extracted with 1000 ml  of methanol for 24 h
with  continuous stirring. The extraction was repeated for
3  days by changing the solvent every 24 h. The extract
was concentrated using rotary vacuum evaporator under
reduced  pressure at 40 ◦C. Known quantity of the dried
extract was subsequently dissolved in 10 mM phosphate
buffered saline (PBS pH 7.4). Centrifugation at 10,800 × g
(for  10 min) was performed for any insoluble. The clear
solution was used for the enzyme inhibition studies. The
venom  activity in absence of plant extract served as the
negative control.rts 1 (2014) 667–673
2.3.  Venom and chemicals
Lyophilized  snake venom (N. naja) was purchased from
Irula  snake catcher’s Industrial co-operative society limited
(Chennai, India). The venom was dissolved in 0.9% saline
and  centrifuged at 675 × g for 10 min  and the supernatant
was  used for the study. Hyaluronic acid was purchased
from Sigma Aldrich (US). All other reagents and solvents
were of high quality analytical grade and were purchased
from SD Fine chemicals/Sisco Research Laboratory Pvt
Ltd/HiMedia, Mumbai.
2.4.  Caseinolytic inhibition
Protease  activity was determined using 1% casein as
substrate in 1% agarose plates according to the method
described previously [9]. 50 g of N. naja venom was  pre-
incubated with various concentrations of plant extract for
1  h at 37 ◦C. Brieﬂy, the pre-incubated samples were loaded
into  3 mm diameter wells of casein-agarose plates (0.1 M
Tris–HCl  buffer, pH 8.0) and incubated overnight at 37 ◦C.
Plates  were then stained with Coomassie Brilliant Blue-R
250  for 1 h and destained with methanol:water:acetic acid
(50:40:10). The percentage of protease inhibition was  cal-
culated  by measuring the zone of clearance in the presence
of  plant extract. Zone of clearance values obtained for the
venom  in the absence of the plant extract served as control.
In  addition to the plate assay, SDS-PAGE was also per-
formed to evaluate the protease inhibition by the plant
extract. Brieﬂy, 50 g of N. naja venom was  pre-incubated
with various concentrations of plant extract for 1 h at 37 ◦C.
These  samples were further incubated with 15 l of 1%
casein (dissolved (w/v) in 0.1 M Tris–HCl buffer, pH 8.0,
37 ◦C). After 30 min, the reaction was stopped by adding
SDS loading buffer (containing 50 mM Tris HCl pH 6.8, 10%
(v/v)  glycerol, 2% (w/v) SDS, 100 mM -mercaptoethanol
and 0.1% (w/v) bromophenol blue). SDS-PAGE of the casein
treated  with venom in presence and absence of plant
extract was then performed according to the method
described previously [10] using 15% acrylamide gel.
2.5.  Phospholipase (PLA2) inhibition
PLA2 inhibition was  evaluated using egg yolk as sub-
strate in 1% agarose plates according to the method
described by Gutierrez et al. [11]. 50 g of N. naja venom
was  pre-incubated with various concentrations of plant
extract for 1 h at 37 ◦C. The pre-incubated samples were
then loaded into 3 mm diameter wells of 1% agarose plates
containing 0.6% egg yolk and 5 mM CaCl2 followed by
overnight incubation at 37 ◦C. The PLA2 inhibition was cal-
culated  by measuring the zone of clearance in the presence
and  absence of plant extract. PLA2 activity of venom in
absence of plant extract served as control.
2.6. Hemolytic inhibitionThe  hemolytic inhibition assay was  carried out as per
the  method described previously [12], with slight modiﬁ-
cations. 100 g of N. naja venom was pre-incubated with
various concentrations of plant extract in a volume of
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within the incubation period of 30 minutes at 37 C. Similar
to  the plate assay results, venom caseinolytic activity was
completely inhibited by the plant extract at a ratio of
1:30  w/w  venom: plant extract. Fig. 2 demonstrates dose
Fig. 1. Dose dependent inhibition of protease activity of N. naja venom by
L.  aspera methanolic extract. 50 g of N. naja venom was pre-incubated
with various concentrations of the plant extract (w/w) for 1 h at 37 ◦C. The
protease activity was assyed by plate method. Venom protease activity in
absence of plant extract was considered as 0% inhibition. Values represent
the mean ± S.D of replicates.
Fig. 2. Inhibition of N. naja venom caseinolytic activity by L. aspera
methanolic extract. 50 g of N. naja venom was pre-incubated with var-
ious concentrations of plant extract (w/w) for 1 h at 37 ◦C. The protease
activity was  assayed in SDS-PAGE method. Lane 1: 50 g of venom; LaneK. Gopi et al. / Toxicolo
00 l PBS for 1 h at 37 ◦C. Brieﬂy, human erythrocytes and
0  mM PBS (pH 7.4) were mixed (1:8 v/v) and 100 l of
his  suspension was incubated with pre-incubated venom
amples for 2 h at 37 ◦C. The reaction was stopped by adding
 ml  of ice cold PBS and centrifuged at 2500 rpm for 10 min
t  4 ◦C. The amount of hemoglobin released in the super-
atant was measured at 540 nm.
.7. Hyaluronidase inhibition assay
Hyaluronidase inhibition assay was performed accord-
ng  to the method of Girish et al. [13] with minor
odiﬁcations. The substrate gel for zymogram was
repared by incorporating hyaluronic acid at a ﬁnal con-
entration of 0.17 mg/ml  into 10% SDS-polyacrylamide gel
atrix.  100 g of N. naja venom was pre-incubated with
ifferent concentrations of plant extract for 1 h at 37 ◦C. All
amples  were prepared under non-reducing conditions for
lectrophoresis. After electrophoresis, the gel was  soaked
ubsequently in 50 ml  of 5% Triton X-100 for 1 h and then in
.05%  Triton X-100 for 30 min  followed by distilled water
or  1 h. The gel was equilibrated in 0.1 M sodium acetate
uffer (pH 5.0) containing 0.15 M NaCl for 48 h at 37 ◦C. The
el  was then washed with distilled water and stained with
.1%  alcian blue solution for 2 h. Destaining was carried out
ith  5% acetic acid until clear translucent bands appeared
gainst dark blue background.
.8.  Phytochemical analysis
In  order to obtain insight into the type of phytochemi-
als present in the extract, analysis was performed as per
he  methods described by Kokate et al. [14].
.9. Gas chromatography–mass spectrometry analysis
Chemical composition of the methanolic extract of L.
spera  was analyzed using a GC–MS GCD-HP1800A system
Hewlett-Packard, USA) equipped with a split/splitless cap-
llary  injection port. The column size was 30 m × 250 m.
n  electron ionization system (Quadruples analyzer; mass
ange,  10–425 amu) with ionization energy of 70 eV was
sed  for GC–MS detection. Each of these steps was  carried
ut  under high vacuum (10−4 to 10−8 Torr). Helium was
sed as a carrier gas at a constant ﬂow rate of 1 ml/min
nd an injection volume of 2 l was employed (split ratio
f  10:1). Injector and mass transfer line temperatures were
et  at 250 ◦C and 280 ◦C, respectively and fragments were
canned from 50 to 600 Da. The components of extract were
dentiﬁed  by comparison with the NIST database.
. Results and discussion
Crude  extracts of plants are being traditionally used
n  the treatment of wide variety of diseases including
nakebite envenomations. However, in most cases the efﬁ-
acy  of this traditional treatment regimen is unproven. In
he  present study, the methanolic extract of L. aspera, one of
he  herbal plants widely used as an antidote by many rural
opulations was evaluated for its efﬁcacy to inhibit selectedrts 1 (2014) 667–673 669
enzymes  in N. naja snake venom. Snake venom metallo-
proteases, phospholipase A2 (PLA2) and hyaluronidases are
the  key enzymes involved in tissue necrosis and extracel-
lular matrix degradation [6,15,16]. Thus, inhibition of these
enzymes  is generally considered to be the rate limiting step
in  the management of snakebite. Therefore, in the present
study, methanolic extract of L. aspera was evaluated for its
potential  to inhibit these major enzymes.
3.1. Protease inhibition
Agar  well diffusion assay indicated that the methanolic
extract of L. aspera completely inhibited the proteolytic
activity of the venom at a ratio of 1:50 (w/w) venom: plant
extract  (Fig. 1). Also, SDS-PAGE analysis indicated that
50  g of N. naja venom was  sufﬁcient to hydrolyse casein
◦2:  casein; Lane 3: casein incubated with venom; Lane 4 to 12: samples
containing casein incubated with venom in presence of different concen-
trations of plant extract i.e. 1:05, 1:10, 1:20 to 1:80 (w/w venom: plant
extract) respectively. Arrows indicate the major bands of casein. Lane 1–3
served as controls.
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Fig. 3. Effect of L. aspera methanolic extract on Naja naja venom Fig. 4. Dose dependent inhibition of N. naja venom hemolytic activity by
L.  aspera methanolic extract. 50 g of N. naja venom was pre-incubatedphosholipaseA2 (PLA2) activity. 50 g of N. naja venom was pre-incubated
with various concentrations of plant extract (w/w) for 1 h at 37 ◦C. PLA2
activity in absence of plant extract was considered as 100% activity. Values
represent the mean ± S.D of replicates.
dependent inhibition of venom caseinolytic activity by L.
aspera  methanolic extract. Snake venom proteases majorly
affect  hemostasis and cause systemic hemorrhage. The
most  probable mechanism involved in the inhibition
of these proteases by plant extracts could be due to
the  chelating property of phenolic components present
in  the extract. It is reported that, phenolic compounds
form hydrogen bonds and strongly bind to the histidine
residues present in Zn2+ binding motifs of metallo pro-
teases, resulting decrease in the hydrolytic activity of
the  enzyme [17]. Melo et al. [18] and Soares et al. [19]
suggested that the plant extracts would have compounds
that bind to divalent metal ions, which are required for
enzymatic activities. As the presence of proper metal ion
coordination is a pre-requisite for the hydrolytic activity
of  metalloproteases, any metabolite that can weaken the
protease-metal ion interaction will result in inhibition of
the  proteolytic activity.
3.2.  Phospholipase inhibition
In  contrast to protease inhibition, the extract com-
pletely failed to neutralize venom PLA2 activity even
at  highest concentration of extract used (Fig. 3). PLA2
causes cardiotoxicity, myotoxicity, pre or postsynaptic
neurotoxicity, edema, hemolysis, hypotension, convul-
sion,  inhibition of platelet aggregation and anticoagulation
[20–22]. Snake venoms are especially rich in group I
(Elapidae) and II (Viperidae) PLA2s. These enzymes are
Ca2+ dependent and hydrolyse the 2-acyl ester bonds
of membrane glycerophospholipids producing free fatty
acids  and lysophospholipids which are key components of
inﬂammatory process. Timely administration of ASV could
neutralize the systemic effects caused by these myotoxic
enzymes but provides no protection against local toxicities
induced by the venom components. Hence, screening of
herbal  antidotes to averse snake venom induced toxic-
ity  is of great importance in the snakebite management
[23]. Hemidesmus indicus root extract had been formerly
reported against Daboia russellii and Naja kaouthia snake
venom  induced toxicities in vivo. Lupeol acetate and 2-
hydroxy-4-methoxy benzoic acid isolated from methanolic
root  extract of H. indicus was demonstrated to have anti-
PLA2 activity against viper and cobra venoms [24,25].with various concentrations of plant extract (w/w) for 1 h at 37 ◦C. The
hemolytic activity in absence of plant extract was considered as 0% inhi-
bition. Values represent the mean ± S.D of replicates.
3.3. Hemolytic inhibition
L.  aspera methanolic extract inhibited the hemolytic
activity of the venom, at a ratio of 1:80 w/w (Fig. 4).
Hemolytic activity is another distinct feature of cobra
venoms greatly induced by multicomponents including
metalloproteases, PLA2, and more speciﬁcally, cardiotoxins
and cytotoxins of venom [26,27]. Though, L. aspera did not
show  inhibition on venom PLA2, it completely protected
the hRBC from direct hemolytic activity of N. naja venom.
As  cardiotoxins and cytotoxins also induce lysis of human
erythrocytes [28], it is possible that the phytochemicals in
the  plant components could inhibit these toxic proteins in
the  venom.
3.4. Hyaluronidase inhibition
100  g of N. naja venom exhibited two  clear bands
of hyaluronidase isomers (in 10% SDS-PAGE zymogram
under non reducing conditions). L. aspera exhibited com-
plete  inhibition of both the isoforms at a ratio of 1:50 w/w
venom-plant extract (Fig. 5). Local tissue damage associ-
ated  with snakebite envenomation is due to the combined
action of metalloproteases along with hyaluronidases and
is  reported to continue even after antisnake venom (ASV)
treatment [29]. Hyaluronidases are a class of endo--
glycosidases that degrade the hyaluronic acid in the cell
wall  and facilitate easy diffusion of venom toxins into cir-
culation,  which would otherwise take much longer time to
diffuse  [30,31].
3.5.  Phytochemical analysis
Qualitative  phytochemical analysis revealed the pres-
ence  of acidic compounds, alkaloids, ﬂavonoids, tannins,
saponins and cardiac glycosides as major components
in the methanolic extract of L. aspera (Table 1). The
anti-venom activity of plants that are widely used against
snake  venom induced toxicity is majorly due to the
presence of various secondary metabolites that bind
directly to venom components and neutralizes their
effect. Flavonoids and alkaloids isolated from differ-
ent plant species demonstrated anti-inﬂammatory and
K. Gopi et al. / Toxicology Reports 1 (2014) 667–673 671
Table 1
Qualitative analysis of the phytochemicals present in methanolic extract of L. aspera.
Phytochemical Test name +/− Phytochemical Test name +/−
Alkali compounds Litmus paper (Red → Blue) − Tannins Ferric chloride test +
Acidic compounds Litmus paper (Blue → Red) + Proteins Biuret test −
Alkaloids Mayers test + Steroids Salkowski test +
Tannic acid test +
Hagers  test +  Triterpenoids Salkowski test −
Carbohydrates Molisch’s test + 
Fats  and ﬁxed oils Glycerin test + 
+ Present, − absent.
Fig. 5. Inhibition of N. naja venom hyaluronidase activity by L. aspera
methanolic extract. 100 g of N. naja venom was pre-incubated with
various concentrations of plant extract (w/w)  for 1 h at 37 ◦C. The
hyaluronidase activity was assayed in substrate gel SDS-PAGE zymogram
under non-reducing conditions. Lane 1 and 8: 100 g of N. naja venom
in absence of plant extract, indicating the presence of two isoforms of
hyaluronidase; Lane 2 to 7: 100 g of venom in presence of different con-
centrations of plant extract i.e. 1:05, 1:10, 1:25, 1:50, 1:75 and 1:100 (w/w
venom: plant extract), respectively, showing dose dependent inhibition of
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Pyaluronidase activity of both the isoforms. Arrows indicate two  isoforms
f venom hyaluronidase.
nti-hemorrhagic effects against various snake venoms.
ome of them are ﬂavonoid-like (Quercetin, kaempferol,
uteolin, myricetin)/alkaloid-like (aristolochic acid and
jmalin)  and have revealed strong inhibitory potential
gainst snake venom hyaluronidases [For recent review,
].  In the present study, L. aspera methanolic extract
howed potent inhibition on protease, hemolytic and
able 2
hytochemicals identiﬁed in the methanolic extract of L. aspera.
S. no. RT Phytochemical name 
1 14.56 Heptane-1-methanesulfonic acid,7,7-dimethyl-2-oxo 
2  14.83 3-Methyl-2-(2-oxopropyl) furan 
3  17.71 Tetradecanoic acid,10,13-dimethyl-methyl ester 
4  18.18 n-Hexadecanoic acid 
5  19.33 Methyl 9-cis,11-trans-octadecadienoate 
6  19.39 Methyl 13-octadecenoate 
7  19.61 Methyl 5-6-octadecqdienoate 
8  19.84 6-Octadecenoic acid 
9  20.08 17-Octadecen-14-yn-1-ol 
10  20.23 2-(Fecnch-2-yl) fenchane 
11  25.48 [1,1-Bicyclohexyl]-4-carboxylic acid, 4′-pentyl-4-pent
12  28.69 Stigmasterol 
13  29.36 Gamma-sitosterol 
14  29.82 Benzene,1-methyl-2-(1-methyl-2-methylenecyclopenSaponins Froth test +
Cardiac glycosides Keller kiliani test +
hyaluronidase activities of N. naja venom. Presence of
these  active secondary metabolites in the extract could
have  contributed for plants anti-venom activity.
3.6. GC/MS and qualitative phytochemical analysis
In order to obtain information on the major metabo-
lites present in the extract, GC–MS was  performed.
Analysis revealed the presence of 6-octadecenoic acid
(32.47%), n-hexadecanoic acid (25.97%), 17-octadecen-
14-yn-1-ol (14.22%), methyl 13-octadecanoate (5.33%),
tetradecanoic acid, 10,13-dimethyl-methyl ester (4.51%),
methyl 5-6-octadecadienoate (3.98%), gamma-sitosterol
(2.45%), stigmasterol (2%) as the major phytoconstituents.
Table 2 describes the phytochemicals identiﬁed in the
extract along with their molecular weight and formula.
Previous reports indicated that tetradecanoic acid binds to
catalytic  site of (Bothrops neuwiedi) venom PLA2 through
hydrogen bonding between ASN27, CYS and HIS47 amino
acid  residues and also by hydrophobic interactions with
neighboring amino acid residues such as LEU2, LEU5,
CYS2, TYR21, PRO17, GLY6, LYS7, ALA18, ILE9, LEU111
and PRO113 present in the catalytic site. Such compet-
itive binding of this molecule is expected to inhibit the
PLA2 activity of the toxin [32]. Also, hexadecanoic acid was
demonstrated to have anti-inﬂammatory activity (Table 3)
through  competitive inhibition of PLA2 [33]. However, in
the  present study the PLA2 activity of N. naja venom was
not  inhibited by the methanolic extract of L. aspera, evenacids.  Sequence analysis indicated (Gopi and Jayaraman,
unpublished results) that the amino acid residues present
in  binding site of the enzyme are signiﬁcantly different at
Mol. formula Mol. (wt) Peak area (%)
C10H16O4S 232 1.52
C8H10O2 138 1.54
C17H34O2 270 4.51
C16H32O2 256 25.97
C19H34O2 294 1.70
C19H36O2 296 5.33
C19H34O2 294 3.98
C18H34O2 282 32.47
C18H32O 264 14.22
C20H34 274 1.36
ylphenyl ester C29H46O2 426 1.38
C29H48O 412 2.00
C29H50O 414 2.45
tyl) C14H18O 202 1.49
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Table 3
Phytochemicals identiﬁed from methanolic extract of L. aspera by GC–MS and their reported bioactivity.
S. no. Phytochemical Compound nature Bioactivity Reference
1 Heptane-1-methanesulfonic acid,7,7-dimethyl-2-oxo Sulfonic acid ester Not reported –
2  3-Methyl-2-(2-oxopropyl) furan Isoprene Strong anti-oxidant [34]
3  Tetradecanoic acid,10,13-dimethyl-methyl ester Myristic acid Anti-inﬂammatory PLA2 inhibition [32]
4  n-Hexadecanoic acid Saturated fatty acids Anti-inﬂammatory PLA2 inhibition [33]
5  Methyl 9-cis,11-trans-octadecadienoate Unsaturated fatty acids Maintains  the cell integrity [36]
6 Methyl 13-octadecenoate Unsaturated fatty acids Maintains  the cell integrity [36]
7 Methyl 5-6-octadecqdienoate Unsaturated fatty acids Maintains the cell integrity [36]
8  6-Octadecenoic acid Saturated fatty acids Synthetic inhibitor of neurotoxins [35]
9  17-Octadecen-14-yn-1-ol Alcohol Not reported
10  2-(Fecnch-2-yl) fenchane Terpenes Anti-snake venom [6]
11  [1,1-Bicyclohexyl]-4-carboxylic
acid,4′-pentyl-4-pentylphenyl ester
Esters Not reported –
12  Stigmasterol Phytosterol Anti-snakevenom [37]
Phyto13  Gamma-sitosterol 
14  Benzene,1-methyl-2-(1-methyl-2-methylenecyclopentyl) 
these positions and therefore resulted in no inhibition of
the  enzymatic activity of phospholipase.
Also, plants having higher the amounts of isoprene
derivatives were demonstrated to have strong antioxi-
dant activity by preventing the free radical formation
[34]. Antioxidants are known to play an important role
in  controlling the neurotoxicity. Hence, the presence of
isoprene  3-methyl-2-(2-oxopropyl) furan in the L. aspera
Fig. 6. Molecular structures of major bioactive phytochemicals from
L. aspera methanolic extract identiﬁed by GC–MS analysis. (1) 6-
octadecenoic acid, (2) n-hexadecenoic acid, (3) 17-octadecen-14-yn-1-ol,
(4) methyl-13-octadecenoic acid, (5) tetradecenoic acid, (6) sitosterol, (7)
stigmasterol.sterol Anti-snake venom [37]
Not reported –
methanolic extract (Table 3) could help in preventing the
oxidative damage caused upon snake envenomations. The
derivatives of octadecenoic acid were reported to be very
strong  synthetic inhibitors of neurotoxins [35]. The unsat-
urated  fatty acids found in the L. aspera methanolic extract
would  help in maintaining the cell integrity which in-
turn  prevents the distribution of venom components from
the  bite site [36]. Apart from isoprene derivatives, octade-
canoic acid derivatives in the extract would also help
in  inhibiting snake venom toxins and their neurotoxic-
ity. Hemorrhage is majorly caused by the combined effect
of  proteases and hyaluronidases. Sitosterol and stigmas-
terol were demonstrated to inhibit viper venom induced
lethality, neurotoxicity and hemorrhage [37]. In the present
study,  protease and hyaluroniade activities were com-
pletely inhibited in a dose dependent manner. This could
be  due to the strong anti-venom activity of the phytoste-
rols (sitosterol and stigmasterol) present in the extract.
Fig. 6 represents some of the major bioactive components
identiﬁed from L. aspera methanolic extract. In addition,
these phytochemicals were previously demonstrated for
their  hyaluronidase inhibition activity by either forming
an  inhibitor-hyaluronic acid complex that restricts the
substrate availability to the enzyme or direct binding to
the  enzyme active site that affects the enzyme activity
[38–40]. Hence, the presence of these multiple bioac-
tive (anti-snake venom) compounds in the extract could
have  contributed for its efﬁcient antivenom activity in the
present  study. Based on the ﬁnding of the present study, it is
demonstrated that methanolic extracts of L. aspera, possess
antivenom activity against N. naja venom enzymes and
supports their traditional use in herbal medicine against
snakebites.
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